Experimental Dermatology
Predictive value of disease activity signs in vitiligo: An observational study
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Causal effects of lipid‐lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Granzyme B inhibition reduces autoantibody‐induced dermal–epidermal separation in an ex vivo model of epidermolysis bullosa acquisita
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Exploration of potential biomarkers for prurigo nodularis based on plasma‐metabolome analysis
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Issue Information
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy
Experimental Dermatology, Volume 33, Issue 9, September 2024.
Experimental Dermatology
Combining dipyridamole and cilostazol with up‐dosing antihistamines improves outcomes in chronic spontaneous urticaria with high D‐dimer levels: A randomized controlled trial
Experimental Dermatology, Volume 33, Issue 8, August 2024.
Experimental Dermatology
Polycyclic aromatic hydrocarbons exposure associated with increased risk of psoriasis
Experimental Dermatology, Volume 33, Issue 8, August 2024.
Experimental Dermatology
The amino acid transporter SLC16A10 promotes melanogenesis by facilitating the transportation of phenylalanine
Experimental Dermatology, Volume 33, Issue 8, August 2024.